Omeros Ownership
| OMER Stock | USD 7.63 0.86 10.13% |
Shares in Circulation | First Issued 2009-03-31 | Previous Quarter 58 M | Current Value 58 M | Avarage Shares Outstanding 40.6 M | Quarterly Volatility 17.4 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Omeros |
Omeros Stock Ownership Analysis
About 44.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.14. Omeros last dividend was issued on the 30th of September 2010. The entity had 1:1.96 split on the 2nd of October 2009. Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington. Omeros Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 213 people. To find out more about Omeros contact the company at 206 676 5000 or learn more at https://www.omeros.com.Omeros Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Omeros is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Omeros backward and forwards among themselves. Omeros' institutional investor refers to the entity that pools money to purchase Omeros' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Royal Bank Of Canada | 2024-09-30 | 497 K | Charles Schwab Investment Management Inc | 2024-09-30 | 485 K | Ubs Group Ag | 2024-09-30 | 450.1 K | Nomura Holdings Inc | 2024-09-30 | 316.3 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 297.9 K | Goldman Sachs Group Inc | 2024-09-30 | 178.2 K | Bank Of America Corp | 2024-09-30 | 176.3 K | Bridgeway Capital Management, Llc | 2024-09-30 | 161.3 K | Susquehanna Fundamental Investments, Llc | 2024-06-30 | 156 K | Ingalls & Snyder Llc | 2024-09-30 | 4.5 M | Blackrock Inc | 2024-06-30 | 4.1 M |
Omeros Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Omeros insiders, such as employees or executives, is commonly permitted as long as it does not rely on Omeros' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Omeros insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Omeros Outstanding Bonds
Omeros issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Omeros uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Omeros bonds can be classified according to their maturity, which is the date when Omeros has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| ON SEMICONDUCTOR P Corp BondUS682189AQ81 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Omeros Corporate Filings
8K | 13th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 3rd of July 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 7th of June 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 27th of March 2024 An amended filing to the original Schedule 13G | ViewVerify |
Pair Trading with Omeros
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Omeros position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will appreciate offsetting losses from the drop in the long position's value.Moving together with Omeros Stock
Moving against Omeros Stock
| 0.84 | AMGN | Amgen Inc | PairCorr |
| 0.75 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.74 | AVDL | Avadel Pharmaceuticals | PairCorr |
| 0.68 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.66 | TTOO | T2 Biosystms | PairCorr |
The ability to find closely correlated positions to Omeros could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Omeros when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Omeros - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Omeros to buy it.
The correlation of Omeros is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Omeros moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Omeros moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Omeros can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Omeros Stock Analysis
When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.